Coming of Age: Molecular Drivers of Aging and Therapeutic Opportunities

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2013 Mar 5

PMID 23454756

Citations 78

Authors

Christopher B Newgard

Norman E Sharpless

Affiliations

Soon will be listed here.

Abstract

Aging is like the weather: everyone talks about it, but no one seems to do anything about it. We believe this may soon change, as an improved understanding of the molecular and genetic pathways underlying aging suggests it is possible to therapeutically target the aging process and increase health span. This Review series focuses on fundamental cellular mechanisms of aging and their relationship to human disease. These pathways include telomere dysfunction in cellular senescence and induction of the senescence-associated secretory phenotype (SASP) in systemic aging, sirtuin family regulation of metabolism and aging-associated diseases, mitochondrial metabolism in aging, the mechanistic target of rapamycin (mTOR) signaling pathway and the use of mTOR inhibitors to increase longevity, the progressive decline of the immune system with age, and aging-associated changes to pancreatic islet β cells that may contribute to diabetes. Together, these articles explore pathways affecting aging and possible interventional targets to slow or delay the onset of age-related pathologies.

Citing Articles

The associations between the energy and timing of sugar-sweetened beverage intake and phenotypic age acceleration in U.S. adults: a cross-sectional survey of NHANES 2007-2010.

Xia T, Yuan Q, Zhang Y, Shan G BMC Public Health. 2025; 25(1):88.

PMID: 39780125 PMC: 11707922. DOI: 10.1186/s12889-024-21249-3.

Critical review of aging clocks and factors that may influence the pace of aging.

Min M, Egli C, Dulai A, Sivamani R Front Aging. 2024; 5:1487260.

PMID: 39735686 PMC: 11671503. DOI: 10.3389/fragi.2024.1487260.

Cross-talk of inflammation and cellular senescence: a new insight into the occurrence and progression of osteoarthritis.

Han Z, Wang K, Ding S, Zhang M Bone Res. 2024; 12(1):69.

PMID: 39627227 PMC: 11615234. DOI: 10.1038/s41413-024-00375-z.

Correlation between organizational support, self-efficacy, and core competencies among long-term care assistants: a structural equation model.

Liu A, Wang D, Xu S, Zhou Y, Zheng Y, Chen J Front Psychol. 2024; 15:1411679.

PMID: 39359970 PMC: 11445756. DOI: 10.3389/fpsyg.2024.1411679.

Association between frailty and activities of daily living disability in older adults residing in a high-altitude Peruvian Andean community: the Aunqui-Andes study.

Urrunaga-Pastor D, Salazar-Talla L, Alcantara-Diaz A, Camacho-Caballero K, Cuba-Ruiz S, Runzer-Colmenares F BMC Geriatr. 2024; 24(1):792.

PMID: 39342104 PMC: 11438180. DOI: 10.1186/s12877-024-05381-8.

References

Flegal K, Carroll M, Ogden C, Curtin L . Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-41. DOI: 10.1001/jama.2009.2014. View

Sinclair D, Verdin E . The longevity of sirtuins. Cell Rep. 2013; 2(6):1473-4. DOI: 10.1016/j.celrep.2012.12.004. View

Jee S, Sull J, Park J, Lee S, Ohrr H, Guallar E . Body-mass index and mortality in Korean men and women. N Engl J Med. 2006; 355(8):779-87. DOI: 10.1056/NEJMoa054017. View

Mattison J, Roth G, Beasley T, Tilmont E, Handy A, Herbert R . Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature. 2012; 489(7415):318-21. PMC: 3832985. DOI: 10.1038/nature11432. View

Pacholec M, Bleasdale J, Chrunyk B, Cunningham D, Flynn D, Garofalo R . SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem. 2010; 285(11):8340-51. PMC: 2832984. DOI: 10.1074/jbc.M109.088682. View

Perez V, Bokov A, Van Remmen H, Mele J, Ran Q, Ikeno Y . Is the oxidative stress theory of aging dead?. Biochim Biophys Acta. 2009; 1790(10):1005-14. PMC: 2789432. DOI: 10.1016/j.bbagen.2009.06.003. View

Kaeberlein M, Kennedy B . Does resveratrol activate yeast Sir2 in vivo?. Aging Cell. 2007; 6(4):415-6. DOI: 10.1111/j.1474-9726.2007.00314.x. View

Bratic A, Larsson N . The role of mitochondria in aging. J Clin Invest. 2013; 123(3):951-7. PMC: 3582127. DOI: 10.1172/JCI64125. View

Kaeberlein M, McVey M, Guarente L . The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev. 1999; 13(19):2570-80. PMC: 317077. DOI: 10.1101/gad.13.19.2570. View

10.

Armanios M . Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest. 2013; 123(3):996-1002. PMC: 3673231. DOI: 10.1172/JCI66370. View

11.

Tyynismaa H, Mjosund K, Wanrooij S, Lappalainen I, Ylikallio E, Jalanko A . Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci U S A. 2005; 102(49):17687-92. PMC: 1308896. DOI: 10.1073/pnas.0505551102. View

12.

Sohal R, Orr W . The redox stress hypothesis of aging. Free Radic Biol Med. 2011; 52(3):539-555. PMC: 3267846. DOI: 10.1016/j.freeradbiomed.2011.10.445. View

13.

Beher D, Wu J, Cumine S, Kim K, Lu S, Atangan L . Resveratrol is not a direct activator of SIRT1 enzyme activity. Chem Biol Drug Des. 2009; 74(6):619-24. DOI: 10.1111/j.1747-0285.2009.00901.x. View

14.

Colman R, Anderson R, Johnson S, Kastman E, Kosmatka K, Beasley T . Caloric restriction delays disease onset and mortality in rhesus monkeys. Science. 2009; 325(5937):201-4. PMC: 2812811. DOI: 10.1126/science.1173635. View

15.

Harman D . Aging: a theory based on free radical and radiation chemistry. J Gerontol. 1956; 11(3):298-300. DOI: 10.1093/geronj/11.3.298. View

16.

Flegal K, Kit B, Orpana H, Graubard B . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82. PMC: 4855514. DOI: 10.1001/jama.2012.113905. View

17.

Chen H, Gu X, Liu Y, Wang J, Wirt S, Bottino R . PDGF signalling controls age-dependent proliferation in pancreatic β-cells. Nature. 2011; 478(7369):349-55. PMC: 3503246. DOI: 10.1038/nature10502. View

18.

Lamming D, Ye L, Sabatini D, Baur J . Rapalogs and mTOR inhibitors as anti-aging therapeutics. J Clin Invest. 2013; 123(3):980-9. PMC: 3582126. DOI: 10.1172/JCI64099. View

19.

Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland J . Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013; 123(3):966-72. PMC: 3582125. DOI: 10.1172/JCI64098. View

20.

Scarpello J . Improving survival with metformin: the evidence base today. Diabetes Metab. 2003; 29(4 Pt 2):6S36-43. DOI: 10.1016/s1262-3636(03)72786-4. View